4//SEC Filing
FINKELSTEIN J J 4
Accession 0000914190-19-000066
CIK 0000707511other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:47 PM ET
Size
17.7 KB
Accession
0000914190-19-000066
Insider Transaction Report
Form 4
FINKELSTEIN J J
DirectorPresident and CEO
Transactions
- Purchase
Convertible Promissory Note (right to buy)
2019-02-27$12500.00/shExercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (104,167 underlying) - Purchase
Common Stock Warrant (right to buy)
2019-02-27+78,125→ 78,125 totalExercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (78,125 underlying)
Holdings
- 1,637,991
Common Stock
- 114,748
Stock Option (right to buy)
Exercise: $0.57Exp: 2019-04-10→ Common Stock (114,748 underlying) - 500,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (500,000 underlying) - 150,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (150,000 underlying) - 35,000
Stock Option (right to buy)
Exercise: $0.16Exp: 2019-04-04→ Common Stock (35,000 underlying) - 500,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (500,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (200,000 underlying) - 250,000
Stock Option (Right to Buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]50,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
- [F3]37,500 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F4]62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001125610
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:47 PM ET
- Size
- 17.7 KB